Lv11
70 积分 2021-04-07 加入
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions
4天前
已完结
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
15天前
已完结
Acute myeloid leukaemia
16天前
已完结
Acute myeloid leukaemia
16天前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
23天前
已完结
Emerging strategies and novel therapeutic targets in acute myeloid leukemia: current advances and future directions
1个月前
已完结
Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia
1个月前
已完结
AML treatment: conventional chemotherapy and emerging novel agents
1个月前
已完结
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial
1个月前
已完结
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies
2个月前
已完结
皖公网安备34019202002308
